1. Home
  2. INVH vs NBIX Comparison

INVH vs NBIX Comparison

Compare INVH & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invitation Homes Inc.

INVH

Invitation Homes Inc.

HOLD

Current Price

$30.11

Market Cap

16.2B

Sector

Finance

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$152.57

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVH
NBIX
Founded
2012
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2B
15.5B
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
INVH
NBIX
Price
$30.11
$152.57
Analyst Decision
Buy
Strong Buy
Analyst Count
18
22
Target Price
$32.50
$180.91
AVG Volume (30 Days)
3.8M
1.4M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
4.28%
N/A
EPS Growth
29.73
41.95
EPS
0.63
3.30
Revenue
$2,729,296,000.00
$161,626,000.00
Revenue This Year
$2.92
$24.73
Revenue Next Year
$2.43
$13.14
P/E Ratio
$48.05
$46.34
Revenue Growth
4.21
977.51
52 Week Low
$24.25
$122.14
52 Week High
$31.38
$186.12

Technical Indicators

Market Signals
Indicator
INVH
NBIX
Relative Strength Index (RSI) 51.57 37.25
Support Level $29.36 $152.67
Resistance Level $30.12 $161.29
Average True Range (ATR) 0.42 4.10
MACD -0.01 -1.08
Stochastic Oscillator 43.60 21.47

Price Performance

Historical Comparison
INVH
NBIX

About INVH Invitation Homes Inc.

Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: